Anaplastic Large Cell Lymphoma
Last Posted: May 18, 2021
- ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.
Parkhi Mayur, et al. Applied immunohistochemistry & molecular morphology : AIMM 2021 4
- Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients.
Lu Suying, et al. Frontiers in oncology 2021 0 598226
- Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
Han Xiaoyu, et al. Scientific reports 2021 3 (1) 5679
- Differentiating synchronous double primary lung adenocarcinomas from intrapulmonary metastasis by CT features, EGFR mutations and ALK rearrangement status.
Han Xiaoyu, et al. Journal of thoracic disease 2020 10 (10) 5505-5516
- Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder.
He Chien-Hui, et al. Journal of the Chinese Medical Association : JCMA 2020 3
- Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
Tevis Sarah E, et al. Aesthetic surgery journal 2019 2
- Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma.
Zing Natalia Pin Chuen et al. Oncology (Williston Park, N.Y.) 2018 Aug 32(8)
- Local Coverage Determination (LCD): Flow Cytometry (L33661)
The U.S. Centers for Medicare & Medicaid Services
- Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma.
Ciambotti Benedetta, et al. Journal of pediatric hematology/oncology 2014 8 (6) e359-65
- Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu Bruce, et al. Medical and pediatric oncology 2003 12 (6) 527-31
- Anaplastic large cell lymphoma
From NCATS Genetic and Rare Diseases Information Center
- Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma.
Cannella Sonia, et al. Cancer 2007 6 (12) 2566-71
- MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
Seidemann Kathrin, et al. Annals of hematology 2006 5 (5) 291-300
- Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann Kathrin, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 11 (33) 8414-21
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.